The authors describe the qualification of an assay with applications for investigating functional comparability of an originator and biosimilar drug.
Fiona Greer BP
Advertisement
Articles by Fiona Greer BP
Does global development have to entail multiple comparability studies?
Advertisement
Latest Updated Articles
Biosimilar Developers Face a Reference-Product DilemmaMarch 1st 2012
Seeking Accelerated Biosimilar CharacterizationOctober 15th 2016
Advertisement
Advertisement
Trending on BioPharm International
1
Opus Genetics’ OPGx-LCA5 Gene Therapy Shows Sustained Vision Gains Ahead of Phase 3
2
BioPharm Brief: Gene Therapy Progress, FDA Approval, and $103M Funding
3
FDA Approves Roche’s Enspryng as First At-Home Subcutaneous Treatment for Thyroid Eye Disease
4
Estuary Biotherapeutics Launches With $103 Million for ADPKD Gene Therapy
5